Journal of Thrombosis and Haemostasis

AIDS, hepatitis and hemophilia in the 1980s: memoirs from an insider
pp. 2065-2069(5)
Author: Mannucci P.M.

Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications – Yes
pp. 2070-2072(3)
Author: Brenner B.

Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications – No
pp. 2073-2074(2)
Author: Middeldorp S.

TAFI and wound healing: closing a knowledge gap
pp. 2075-2077(3)
Author: Boffa M.B.

Thrombin's faces revealed: cellular effects include induction of neoangiogenesis
pp. 2078-2080(3)
Author: Bahou W.F.

Roles of factor XI, platelets and tissue factor-initiated blood coagulation
pp. 2081-2086(6)
Author: Walsh P.N.

Impaired healing of cutaneous wounds and colonic anastomoses in mice lacking thrombin-activatable fibrinolysis inhibitor
pp. 2087-2096(10)
Authors: Te Velde E.A.; Wagenaar G.T.M.; Reijerkerk A.; Roose-Girma M.; Borel Rinkes I.H.M.; Voest E.E.; Bouma B.N.; Gebbink M.F.B.G.; Meijers J.C.M.

Thrombin induces neoangiogenesis in the chick chorioallantoic membrane
pp. 2097-2102(6)
Authors: Caunt M.; Huang Y-Q.; Brooks P.C.; Karpatkin S.

The function of factor XI in tissue factor-initiated thrombin generation
pp. 2103-2111(9)
Authors: Butenas S.; Dee J.D.; Mann K.G.

Nitric oxide in vascular biology
pp. 2112-2118(7)
Authors: Walford G.; Loscalzo J.

Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study
pp. 2119-2130(12)
Authors: Colwell C.W.; Berkowitz S.D.; Davidson B.L.; Lotke P.A.; Ginsberg J.S.; Lieberman J.R.; Neubauer J.; Mcelhattan J.L.; Peters G.R.; Francis C.W.

Is mild normobaric hypoxia a risk factor for venous thromboembolism?
pp. 2131-2133(3)
Authors: Hodkinson P.D.; Hunt B.J.; Parmar K.; Ernsting J.

Thrombophilic families with inheritably associated high levels of coagulation factors VIII, IX and XI
pp. 2134-2139(6)
Authors: Lavigne G.; Mercier E.; Queré I.; Dauzat M.; Gris J.-C.

Prospective double-blind randomized study of the effects of four intravenous fluids on platelet function and hemostasis in elective hip surgery
pp. 2140-2148(9)
Authors: Evans P.A.; Heptinstall S.; Crowhurst E.C.; Davies T.; Glenn J.R.; Madira W.; Davidson S.J.; Burman J.F.; Hoskinson J.; Stray C.M.

Effect of tamoxifen at low doses on ultrasensitive C-reactive protein in healthy women
pp. 2149-2152(4)
Authors: Bonanni B.; Johansson H.; Gandini S.; Guerrieri-Gonzaga A.; Sandri M.T.; Mariette F.; Lien E.A.; Decensi A.

Thrombosis in inherited factor VII deficiency
pp. 2153-2158(6)
Authors: Mariani G.; Herrmann F.H.; Schulman S.; Batorova A.; Wulff K.; Etro D.; Dolce A.; Auerswald G.; Astermark J.; Schved J.-F.; Ingerslev J.; Bernardi F.

Recognition of coagulation factor VIII by CD4+ T cells of healthy humans
pp. 2159-2166(8)
Authors: Hu G-L.; Okita D.K.; Diethelm-Okita B.M.; Conti-Fine B.M.

The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery
pp. 2167-2174(8)
Authors: Gordois A.; Posnett J.; Borris L.; Bossuyt P.; Jönsson B.; Levy E.; De Pouvourville G.

Enhanced in vitro procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in severe hemophilia A
pp. 2175-2178(4)
Authors: Lisman T.; De Groot P.G.; Lambert T.; Røjkjær R.; Persson E.

A functional haplotype in the 5 flanking region of the factor VII gene is associated with an increased risk of coronary heart disease
pp. 2179-2185(7)
Authors: Carew J.A.; Basso F.; Miller G.J.; Hawe E.; Jackson A.A.; Humphries S.E.; Bauer K.A.

Interaction between oral contraceptive use and coagulation factor levels in deep venous thrombosis
pp. 2186-2190(5)
Authors: van Hylckama Vlieg A.; Rosendaal F.R.

Measurement of von Willebrand factor activity: relative effects of ABO blood type and race
pp. 2191-2197(7)
Authors: Miller C.H.; Haff E.; Platt S.J.; Rawlins P.; Drews C.D.; Dilley A.B.; Evatt B.

Identification of a novel point mutation in platelet glycoprotein Ib, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease
pp. 2198-2205(8)
Authors: Matsubara Y.; Murata M.; Sugita K.; Ikeda Y.

Redistribution of glycoprotein Ib within platelets in response to protease-activated receptors 1 and 4: roles of cytoskeleton and calcium
pp. 2206-2215(10)
Authors: Han Y.; Nurden A.; Combrié R.; Pasquet J-M.

Involvement of the ₃ E⁷⁴⁹ATSTFTN⁷⁵⁶ region in stabilizing integrin _IIb3-ligand interaction
pp. 2216-2224(9)
Authors: Litjens P.E.M.H.; Gorter G.; Ylänne J.; Akkerman J-W.N.; van Willigen G.

Aspirin and salicylate inhibit colon cancer medium- and VEGF-induced endothelial tube formation: correlation with suppression of cyclooxygenase-2 expression
pp. 2225-2233(9)
Authors: Shtivelband M.I.; Juneja H.S.; Lee S.; Wu K.K.

Intimal preatherosclerotic thickening of the coronary arteries in human fetuses of smoker mothers
pp. 2234-2238(5)
Authors: Matturri L.; Lavezzi A.M.; Ottaviani G.; Rossi L.

Screening of high factor VIII levels is not recommended in patients with recently diagnosed pulmonary embolism
pp. 2239-2240(2)
Authors: Kamphuisen P.W.; ten Wolde M.; Jacobs E.M.G.; Ullmann E.F.; Büller H.R.

Availability of technology to evaluate for pulmonary embolism in academic emergency departments in the United States
pp. 2240-2242(3)
Authors: Jones A.E.; Kline J.A.

Prevalence of inherited bleeding disorders in cases of idiopathic menorrhagia: a case of five blind men describing an elephant
pp. 2242-2243(2)
Authors: Ghosh K.; Trasi S.; Nair S.; Shetty S.; Mohanty D.

Very high TAFI antigen levels are associated with a lower risk of hard coronary events: the PRIME Study
pp. 2243-2244(2)
Authors: Juhan-Vague I.; Morange P.E.

Role of the fibrinogen -chain sequence 316–322 in platelet-mediated clot retraction
pp. 2245-2246(2)
Authors: Remijn J.A.; IJsseldijk M.J.W.; de Groot P.G.

A common mutation in 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in two Arab communities
pp. 2246-2248(3)
Authors: Al-Habboubi H.; Tamim H.; Ameen G.; Almawi W.Y.

Evidence of platelet activation due to tirofiban-dependent platelet antibodies: double trouble
pp. 2248-2250(3)
Authors: Dunkley S.; Lindeman R.; Evans S.; Casten R.; Jepson N.

Antibodies to tissue factor pathway inhibitor are uncommonly detected in patients with infection-related antiphospholipid antibodies
pp. 2250-2251(2)
Authors: Forastiero R.R.; Martinuzzo M.E.; De Larrañaga G.; Broze G.J.

Warfarin and acenocoumarol dose requirements according to CYP2C9 genotyping in North-Italian patients
pp. 2252-2253(2)
Authors: Spreafico M.; Peyvandi F.; Pizzotti D.; Moia M.; Mannucci P.M.

Prothrombin G20210A is not prevalent in North India
pp. 2253-2254(2)
Authors: Garewal G.; Das R.; Ahluwalia J.; Mittal N.; Varma S.

A different view of ‘Toc’, as I knew him
pp. 2255-2255(1)
Author: Green D.

Milder bleeding tendency in Glanzmann's thrombasthenia patients inheriting HPA-1b in the homozygous state
pp. 2255-2256(2)
Authors: Ghosh K.; Nair S.; Kulkarni B.; Shetty S.; Mohanty D.

Rebuttal to: LMWH vs. LMWH: superior, equivalent or non-inferior?
pp. 2256-2258(3)
Authors: Rocha E.; Planès A.

LMWH contra LMWH: superior, equivalent or non-inferior? Reply to a rebuttal
pp. 2259-2259(1)
Authors: Bounameaux H.; Perrier A.

Talking about…
pp. 2260-2263(4)
Authors: Bruttomesso G.; Miglino N.

Announcements
pp. 2264-2265(2)

Addendum
pp. 2266-2266(1)